"Anti-Inflammatory Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that reduce or suppress INFLAMMATION.
| Descriptor ID |
D000893
|
| MeSH Number(s) |
D27.505.954.158
|
| Concept/Terms |
Anti-Inflammatory Agents- Anti-Inflammatory Agents
- Anti Inflammatory Agents
- Agents, Antiinflammatory
- Antiinflammatories
- Antiinflammatory Agents
- Agents, Anti-Inflammatory
- Agents, Anti Inflammatory
- Anti-Inflammatories
- Anti Inflammatories
|
Below are MeSH descriptors whose meaning is more general than "Anti-Inflammatory Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Inflammatory Agents".
This graph shows the total number of publications written about "Anti-Inflammatory Agents" by people in this website by year, and whether "Anti-Inflammatory Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 5 | 7 |
| 1997 | 3 | 4 | 7 |
| 1998 | 6 | 0 | 6 |
| 1999 | 4 | 1 | 5 |
| 2000 | 0 | 1 | 1 |
| 2001 | 6 | 7 | 13 |
| 2002 | 3 | 3 | 6 |
| 2003 | 5 | 4 | 9 |
| 2004 | 3 | 3 | 6 |
| 2005 | 7 | 4 | 11 |
| 2006 | 5 | 4 | 9 |
| 2007 | 10 | 6 | 16 |
| 2008 | 5 | 3 | 8 |
| 2009 | 10 | 2 | 12 |
| 2010 | 7 | 6 | 13 |
| 2011 | 8 | 6 | 14 |
| 2012 | 5 | 6 | 11 |
| 2013 | 8 | 5 | 13 |
| 2014 | 13 | 5 | 18 |
| 2015 | 6 | 5 | 11 |
| 2016 | 5 | 3 | 8 |
| 2017 | 9 | 2 | 11 |
| 2018 | 8 | 6 | 14 |
| 2019 | 8 | 1 | 9 |
| 2020 | 5 | 9 | 14 |
| 2021 | 6 | 1 | 7 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 5 | 6 |
| 2025 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Inflammatory Agents" by people in Profiles.
-
Bioinspired nano-micron hydrogel microspheres for periodontitis therapy through synergistic multi-targeted remodeling of microenvironment. Theranostics. 2025; 15(14):6857-6881.
-
Optimizing Pediatric Asthma Management: Implementation and Evaluation of Anti-Inflammatory Reliever and Single Maintenance and Reliever Therapies. J Allergy Clin Immunol Pract. 2025 Jul; 13(7):1507-1515.
-
Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. Am J Physiol Gastrointest Liver Physiol. 2025 Jun 01; 328(6):G696-G715.
-
Evaluation of LYR-220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study. Int Forum Allergy Rhinol. 2025 Aug; 15(8):818-827.
-
Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseases. Clin Exp Rheumatol. 2025 Jan; 43(1):119-125.
-
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial. Cardiovasc Res. 2024 05 29; 120(7):678-680.
-
Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models. Cells. 2024 02 25; 13(5).
-
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024 Feb 06; 15(1):974.
-
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. J Med Chem. 2024 02 22; 67(4):2712-2731.
-
Large-scale computational modelling of the M1 and M2 synovial macrophages in rheumatoid arthritis. NPJ Syst Biol Appl. 2024 Jan 26; 10(1):10.